文献速递创伤与烧伤儿科与产科急症重症综合管理与镇静镇痛

延迟启动静脉血栓栓塞预防增加创伤性出血患儿静脉血栓栓塞发生率

Waiting to initiate venous thromboembolism prophylaxis increases the incidence of venous thromboembolism in pediatric patients with traumatic bleeding.
PubMed 文献 · J Trauma Acute Care Surg · 2025-06-13
一句话结论创伤性出血患儿每延迟1天启动VTE预防,VTE风险增加6%(OR 1.06,95%CI 1.03-1.10),<15岁亚组增加4%(OR 1.04,1.01-1.07)。

该研究为急性外科创伤质量改进项目数据库(2020-2022)的回顾性分析,纳入4575例18岁以下、到达后4小时内接受血制品或止血手术的创伤患儿。VTE发生率为4%(185例),预防启动率为51%,中位启动时间2(2-4)天。多因素分析显示,每延迟1天启动VTE预防,VTE风险增加6%(OR 1.06,95%CI 1.03-1.10,p<0.001);<15岁亚组(VTE发生率3%)同样持续(OR 1.04,1.01-1.07,p=0.04)。结论提示更早启动VTE预防与降低VTE风险相关,未来需多中心研究评估安全性和药物选择。

要点

  • 在高危创伤出血患儿中,每延迟1天启动VTE预防,VTE风险增加6%(OR 1.06,95%CI 1.03-1.10,p<0.001)。
  • 年龄<15岁亚组VTE发生率为3%,每延迟1天启动VTE预防,VTE风险增加4%(OR 1.04,95%CI 1.01-1.07,p=0.04)。
  • 总体VTE发生率为4%(185/4575),其中深静脉血栓和/或肺栓塞分别为154例和45例。
  • VTE预防启动率为51%,常用药物为低分子肝素(38%)和普通肝素(11%),中位启动时间2(2-4)天。
  • VTE组较非VTE组年龄更大(16[15-17]岁 vs 16[13-17]岁)、损伤严重度评分更高(27[19-36] vs 25[14-35])、到达时休克指数(儿童年龄校正)比例更高(75% vs 64%)。

适用人群与场景

  • 18岁以下创伤患儿,且在到达后4小时内接受血制品或接受止血手术。
  • 数据来源为急性外科创伤质量改进项目数据库(2020-2022)。

研究设计与关键结果

  • 回顾性分析纳入4575例患儿,其中3902例接受止血手术,4141例接受血制品输注。
  • 185例(4%)发生VTE(深静脉血栓和/或肺栓塞分别为154例和45例)。
  • VTE预防启动率为51%,常用药物为低分子肝素(38%)和普通肝素(11%),中位启动时间2(2-4)天。
  • 多因素分析显示,每延迟1天启动VTE预防,VTE风险增加6%(OR 1.06,95%CI 1.03-1.10,p<0.001)。
  • 年龄<15岁亚组VTE发生率为3%,每延迟1天启动VTE预防,VTE风险增加4%(OR 1.04,95%CI 1.01-1.07,p=0.04)。
  • VTE组较非VTE组年龄更大(16[15-17]岁 vs 16[13-17]岁)、损伤严重度评分更高(27[19-36] vs 25[14-35])、到达时休克指数(儿童年龄校正)比例更高(75% vs 64%)。

证据类型、等级与局限

  • 证据类型:回顾性分析(急性外科创伤质量改进项目数据库,2020-2022)。
  • 证据等级:治疗/护理管理;Level III。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,在该高危创伤出血患儿队列中,更早启动VTE预防与降低VTE风险相关,提示有机会优化VTE预防。
  • 作者指出,未来需多中心研究评估安全性和治疗药物选择。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: We aim to evaluate the relationship between timing of venous thromboembolism (VTE) prophylaxis initiation and incidence of VTE in a high-risk cohort of injured children.

METHODS: This is a retrospective analysis of the Acute Care Surgery Trauma Quality Improvement Program database (2020-2022). Injured children (younger than 18 years) who received blood products or underwent hemorrhage control surgery within 4 hours of arrival were included. The primary outcome was VTE (deep venous thrombosis or pulmonary embolism). Multivariable analysis assessed the relationship between timing of VTE prophylaxis and VTE, adjusting for prophylaxis agent, type of surgery, head injury severity, interfacility transfer, total 4-hour blood product administration, injury mechanism, Injury Severity Score, age, sex, and trauma center level, clustered by facility. Missing data were imputed. Subgroup analyses include age younger than 15 years.

RESULTS: Of 4,575 children included, 3,902 underwent hemorrhage control surgery, and 4,141 received blood product transfusion. In total, 185 (4%) developed VTE (n = 154 deep venous thrombosis and/or n = 45 pulmonary embolism). The VTE cohort was older (16 [15-17] vs. 16 [13-17] years), had higher Injury Severity Score (27 [19-36] vs. 25 [14-35]), and was more likely to be in shock on arrival based on shock index, pediatric age-adjusted score (75% vs. 64%). The rate of prophylaxis was 51%, with common agents being low-molecular-weight heparin (38%) and unfractionated heparin (11%). The median (interquartile range) time to initiation of prophylaxis was 2 (2-4) days. In the multivariable analysis, every 1-day delay to initiation of VTE prophylaxis was associated with 6% increase in odds of VTE (odds ratio [95% confidence interval], 1.06 [1.03-1.10]; p < 0.001). In a subset of children younger than 15 years with VTE incidence of 3%, this relationship persisted (every 1-day delay = 4% increase in odds of VTE; odds ratio, 1.04 [1.01-1.07]; p = 0.04).

CONCLUSION: Earlier VTE prophylaxis initiation was associated with decreased odds of VTE development in this high-risk pediatric cohort, highlighting opportunities to optimize VTE prevention. Future multicenter studies regarding safety and therapeutic agent of choice are required.

LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.

来源:J Trauma Acute Care Surg,查看原文。版权归原作者所有。

参考来源

  1. Feeney E, Morgan KM, Furman L, et al. Waiting to initiate venous thromboembolism prophylaxis increases the incidence of venous thromboembolism in pediatric patients with traumatic bleeding. J Trauma Acute Care Surg. 2025. PMID: 40506816. doi:10.1097/TA.0000000000004670

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。